Stability-indicating capillary zone electrophoresis method for the assessment of recombinant human granulocyte-macrophage colony-stimulating factor and its correlation with reversed-phase liquid chromatography method and bioassay

被引:13
作者
Dalmora, Sergio Luiz [1 ]
Butzge, Cairo dos Santos [1 ]
Machado, Francine Trevisan [1 ]
Walter, Mauricio Elesbao [1 ]
de Avila Dalmora, Maria Elisabeth [1 ]
Souto, Ricardo Bizogne [1 ]
机构
[1] Univ Fed Santa Maria, Dept Ind Pharm, BR-97105900 Santa Maria, RS, Brazil
关键词
Capillary zone electrophoresis; Reversed-phase liquid chromatography; Recombinant human granulocyte-macrophage colony-stimulating factor; Cell culture; Biotechnology; FACTOR GM-CSF; VALIDATION; FORMULATIONS; ROBUSTNESS; QUALITY;
D O I
10.1016/j.talanta.2012.03.015
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A stability-indicating capillary zone electrophoresis (CZE) method was validated for the analysis of granulocyte-macrophage colony-stimulating factor (rhGM-CSF) using leuprorelin acetate (LA), as internal standard (IS). A fused-silica capillary (75 mu m id.: effective length, 72 cm) was used at 25 degrees C; the applied voltage was 12 kV. The background electrolyte solution consisted of 50 mM di-sodium hydrogen phosphate solution at pH 8.8. Injections were performed using a pressure mode at 50 mbar for 9 s, with detection by photodiode array detector set at 200 nm. Specificity and stability-indicating capability were established in degradation studies, which also showed that there was no interference of the excipients. The method was linear over the concentration range of 2.5-200 mu g mL(-1) (r(2) = 0.9995) and the limit of detection (LOD) and limit of quantitation (LOQ) were 0.79 mu g mL(-1) and 2.5 mu g mL(-1), respectively. The accuracy was 99.14% with bias lower than 1.40%. The method was applied to the quantitative analysis of biopharmaceutical formulations, and the results were correlated to those of a validated reversed-phase LC method (RP-LC), and an in vitro bioassay, showing non-significant differences (p > 0.05). (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 33 条
[1]   Overview of the status and applications of capillary electrophoresis to the analysis of small molecules [J].
Altria, KD ;
Elder, D .
JOURNAL OF CHROMATOGRAPHY A, 2004, 1023 (01) :1-14
[2]  
[Anonymous], 2003, Q1A (R2), current step, V4, P1, DOI DOI 10.1136/BMJ.333.7574.873-A
[3]   ANALYSIS OF THERAPEUTIC GROWTH-HORMONE PREPARATIONS - REPORT OF AN INTERLABORATORY COLLABORATIVE STUDY ON GROWTH-HORMONE ASSAY METHODOLOGIES [J].
BRISTOW, AF ;
JEFFCOATE, SL .
BIOLOGICALS, 1992, 20 (03) :221-231
[4]  
CEBON J, 1988, BLOOD, V72, P1340
[5]   Granulocyte macrophage-colony stimulating factor shows anti-apoptotic activity in neural progenitor cells via JAK/STAT5-Bcl-2 pathway [J].
Choi, Jung Kyoung ;
Kim, Kil Hwan ;
Park, Hyeonseon ;
Park, So Ra ;
Choi, Byung Hyune .
APOPTOSIS, 2011, 16 (02) :127-134
[6]   Development and validation of a capillary zone electrophoresis method for assessment of recombinant human granulocyte colony-stimulating factor in pharmaceutical formulations and its correlation with liquid chromatography methods and bioassay [J].
Dalmora, Sergio Luiz ;
D'Avila, Felipe Bianchini ;
da Silva, Lucelia Magalhaes ;
Bergamo, Ana Claudia ;
Zimmermann, Estevan Sonego .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (24) :2471-2476
[7]   Immunogenicity of protein therapeutics [J].
De Groot, Anne S. ;
Scott, David W. .
TRENDS IN IMMUNOLOGY, 2007, 28 (11) :482-490
[8]   Ruggedness and robustness testing [J].
Dejaegher, Bieke ;
Vander Heyden, Yvan .
JOURNAL OF CHROMATOGRAPHY A, 2007, 1158 (1-2) :138-157
[9]   Study of aggregation, denaturation and reduction of interferon alpha-2 products by size-exclusion high-performance liquid chromatography with fluorescence detection and biological assays [J].
Diress, Abebaw ;
Lorbetskie, Barry ;
Larocque, Louise ;
Li, Xuguang ;
Alteen, Matthew ;
Isbrucker, Richard ;
Girard, Michel .
JOURNAL OF CHROMATOGRAPHY A, 2010, 1217 (19) :3297-3306
[10]  
Ermer J, 2005, METHOD VALIDATION IN PHARMACEUTICAL ANALYSIS: A GUIDE TO BEST PRACTICE, P1